video corpo
Add to favorites

#Industry News

CMS increases Medicare coverage for diabetes to include continuous glucose monitors that interface with Medtronic insulin pumps.

“We applaud CMS for taking action to assist more individuals with diabetes and allowing them to chose the treatments that best fit their diabetes management requirements,” said Jeff Farkas, vice president of Medtronic’s Diabetes unit for health economics, reimbursement, and government relations.

DUBLIN, Ireland, December 22, 2021 /PRNewswire(opens new window)/ — Medtronic plc (NYSE:MDT), a worldwide leader in healthcare technology, said today that the Centers for Medicare & Medicaid Services (CMS) in the United States would extend Medicare coverage for all kinds of continuous glucose monitors (CGMs), including adjunctive and non-adjunctive CGMs.

Details

  • Che Ye Lu, Song Jiang Qu, Shang Hai Shi, China, 201611
  • BQ PLUS MEDICAL

    Products associated